Skip to content

Novel 3D Printed Knee Brace for Medial Knee Osteoarthritis

A 3D Printed Knee Brace to Improve Symptoms, Biomechanics and Daily Life Among Medial Knee Osteoarthritis Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02873403
Enrollment
10
Registered
2016-08-19
Start date
2017-03-31
Completion date
2017-06-30
Last updated
2017-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Knee

Brief summary

Around 250 millions of people in the world (3.8%) have knee osteoarthritis (KOA). Due to aging and increasing obesity, the prevalence of KOA is expected to increase in the developed country in the next 20 years. KOA decreases quality of life of patients through chronic pain, joint stiffness, and reduced social activity, which influence emotional wellness as well. KOA has also impact on the biomechanics of the lower limbs, leading or amplifying the tibiofemoral misalignment and an increase of the medial knee joint loading. Increase of the medial knee joint loading may lead patients into a vicious circle by increasing knee pain, decreasing activities, increasing weight and disease progression. Knee brace is a non-pharmacological treatment recommended for KOA. It aims to reduce misalignment of the limb. However, the main issue is the poor compliance because of lack of effectiveness, more drawbacks than benefits, discomfort, bad fitting, migration of the brace, bulkiness, aesthetic, skin irritation, blisters and too much pressure on the knee. By its freedom in design, 3D printing may resolve most of these complaints. This study aims to compare clinical and biomechanical effectiveness, comfort and patients complaints of a knee brace made by 3D printing to a conventional knee brace. The institute for Applied Health Research of Glasgow Caledonian University (GCU) will lead the experimental trial. They will recruit men or women (40 to 70 years old) suffering from medial KOA in Glasgow area. Participants will be in study for 10 weeks. During this period, they will wear 2 different knee braces for two weeks each with a 1-week period without knee brace between. Participants will have five visits to GCU: once for leg measurement to make knee braces and four times to fill questionnaires and perform gait analysis. Besides, they will wear activity monitor for 3 non-consecutive weeks.

Interventions

DEVICEKNEEMO knee brace

Bespoke knee brace made by additive manufacturing

DEVICEPopular knee brace

Customized knee brace used in the management of medial knee ostearthritis

Sponsors

Glasgow Caledonian University
CollaboratorOTHER
Universität Münster
CollaboratorOTHER
Peacocks Medical Group
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Male or female aged between 40 and 70 years old having radiological and symptomatic medial KOA (Kellgren-Lawrence grade II, III or IV) according to the American College of Rheumatology's clinical and radiological criteria \[83\] * Average knee pain \> 4/10 (VAS score assessed three times in two weeks before being included) * Not currently wearing knee brace * Varus knee alignment equal or superior to 2° * No or light pain from the hips, ankles, feet or lumbar spine * Moderately physically active * Able to understand written and spoken English.

Exclusion criteria

* Mild KOA (Kellgren-Lawrence grade I) * Lateral or patellar KOA * Chronic diseases or conditions (e.g., diabetes, osteoporosis, heart disease, hypertension, neurological disorders) * Stroke history * Inflammatory arthritis (gout, RA, psoriatic arthritis, …) * Musculoskeletal disorders that could influence their ability to stand and walk * Morbid obesity (BMI \> 35) * Intra-articular corticosteroid/hyaluronan injection in the affected knee in the past 3 months * Unstable medication schedule and medication that causes dizziness * Severe recent modification of diet * Prosthetic implants in the hip, knee or ankle joint * Poor skin condition * Unable to walk, walk up and down stairs or any condition contraindicating the demands of the gait analysis.

Design outcomes

Primary

MeasureTime frameDescription
Change in knee pain during gait and stairs ambulationBaseline and at 2 weeksMeasured with 10-cm visual analog scale
Change in knee adduction moment during gait and stairs ambulationBaseline and at 2 weeksKnee adduction moment (KAM) will be calculated from motion capture and force plate data. KAM characterizes knee loading, especially peaks and angular impulse (area under the KAM curve) to have information about maximum and total knee loading, respectively.

Secondary

MeasureTime frameDescription
Change in knee brace comfortBaseline and at 2 weeksMeasured with 10-cm visual analog scale
Change in stability feelingsBaseline and at 2 weeksMeasured with 10-cm visual analog scale
Change in SymptomsBaseline and at 2 weeksKOOS questionnaires subscales
Change in quality of lifeBaseline and at 2 weeksMOS SF-36 questionnaires subscales
Change in physical activities: Daily distance estimateSecond week of interventionMeasured (in km) during one week with an activity monitor.
Change in physical activities: Daily duration of sitting/standing/stair climbingSecond week of interventionMeasured in seconds during one week with an activity monitor.
Change in physical activities: Daily number of sitting/standing/stair climbingSecond week of interventionMeasured during one week with an activity monitor.
Change in physical activities: Weekly number of activities with moderate and high intensitySecond week of interventionMeasured during one week with an activity monitor.
Change in physical activities: Weekly duration of activities with moderate and high intensitySecond week of interventionMeasured in minutes during one week with an activity monitor.
Change in knee flexion moment during gait and stairs ambulationBaseline and at 2 weeksMaximum knee flexion moment will be calculated from gait analysis data.
Change in duration of phases of gait and stairs ambulationBaseline and at 2 weeksMeasured in percentage of gait cycle from gait analysis data.
Change in step length of gaitBaseline and at 2 weeksMeasured in meters from gait analysis data
Change in knee flexion/extension range of motion during gait and stairs ambulationBaseline and at 2 weeksMeasured during the gait cycle based on gait analysis data
Change in knee adduction/abduction range of motion during gait and stairs ambulationBaseline and at 2 weeksMeasured during the gait cycle based on gait analysis data

Countries

United Kingdom

Contacts

Primary ContactYoann Dessery, PhD
yoann.dessery@peacocks.net
Backup ContactJari Pallari, PhD
jari.pallari@peacocks.net

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026